Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting PDE10A for potential treatment of neurological disorders such as schizophrenia and Huntington’s disease. Its structure enables selective binding and modulation of enzyme activity, making it valuable in developing central nervous system therapeutics. Also explored in medicinal chemistry for optimizing drug candidates due to its favorable pharmacokinetic properties and ability to cross the blood-brain barrier.